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Summary
Objective: The ability to reliably quantify all the structural abnormalities in osteoarthritis (OA) of the knee is a long-standing goal of OA
research. On December 5 and 6, 2002, Outcome Measures in Rheumatology Clinical Trials and Osteoarthritis Research Society, International
held a Workshop for Consensus on Osteoarthritis Imaging in Bethesda, MD, with the aim of providing a state-of-the-art review of imaging out-
come measures for OA of the knee. As part of the Workshop, data from previous clinical trials and epidemiological studies of OA were
analysed with respect to the metrological properties of the measurement methods used. The following report outlines the results of analyses
aimed at evaluating the internal construct validity of a whole-organ, ordinal (semi-quantitative) magnetic resonance imaging score (WORMS)
using Rasch analysis. The ﬁt of data to the Rasch model offers a measure of the validity of summing different items into a subscale score and
the degree to which this score behaves as a unidimensional, interval level measurement tool.
Methods: The Rasch model was applied in two OA studies. The ﬁrst was a clinical cohort comprising OA knee subjects entering a clinical trial;
study entry criteria included patients with at least moderate pain, radiographic osteophytes and a minimum of 1.5 mm tibiofemoral joint-space
width. The second cohort was from the Boston Osteoarthritis Knee Study, an observational cohort of subjects with symptomatic knee OA with
pain on most days and a deﬁnite osteophyte in either the tibiofemoral or patellofemoral joints. Baseline WORMS scores from both studies were
used for the Rasch analysis, performed with RUMM 2020 software.
Results: There was a substantial proportion of subjects in both study populations with zero scores in several of the subscales of WORMS. Few
of the subscales met the requirements of the Rasch measurement model when summated across all sites, and summations of some postu-
lated compartmentally based sites also failed to ﬁt the Rasch model. The existing scoring categories also required rescoring at many sites.
Conclusion: There remain important issues in constructing outcome measurements that summate different features across multiple anatom-
ical sites. The whole-organ scoring system evaluated here is no exception. Resolving these issues will improve the ability of imaging studies to
assess complex pathological structural change.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyOn December 5 and 6, 2002, Outcome Measures in Rheu-
matology Clinical Trials and Osteoarthritis Research Soci-
ety, International (OARSI), with support from various
pharmaceutical companies listed at the beginning of this
supplement, held a Workshop for Consensus on Osteoar-
thritis Imaging in Bethesda, MD. The overall aim of the
workshop was to provide a state-of-the-art review of imag-
ing outcome measurement in osteoarthritis (OA) to help
guide scientists and pharmaceutical companies in design-
ing and conducting multi-centre clinical studies of knee
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were initially reviewed by a multidisciplinary, international
panel of expert scientists and physicians from academia,
the pharmaceutical industry and regulatory agencies. The
panel was co-chaired by Charles Peterfy, M.D., Ph.D.
(Synarc, Inc., San Francisco, CA, USA) and Roy Altman,
M.D., (University of Miami, Miami, FL, USAa) and also in-
cluded Deborah Burstein, Ph.D. (HarvardeMIT, Cambridge,
MA, USA), Flavia Cicuttini (Epidemiology, Monash Univer-
sity, Prahran, Australia), Gary Cline, Ph.D. (Biometrics
and Statistical Sciences, Proctor & Gamble Pharmaceuti-
cals, Madison, OH, USA), Philip Conaghan, M.B.B.S.,
F.R.A.C.P., (Rheumatology, Leeds University, Leeds, UK),
Bernard Dardzinski, Ph.D. (MRI Physics, University of Cin-
cinnati, Cincinnati, USA), Felix Eckstein, M.D. (MR image
aDr Altman is currently at UCLA, CA, USA.
A117Osteoarthritis and Cartilage Vol. 14, Supplement Aanalysis, Ludwig-Maximilians-Universita¨t, Mu¨nchen, Ger-
manyb), David Felson, M.D., M.P.H. (Rheumatology, Bos-
ton University, Boston, MA, USA), Garry Gold, M.D.,
Ph.D. (Radiology, Stanford University, Stanford, CA,
USA), Benjamin Hsu, Ph.D. (GlaxoSmithKline, Research
Triangle Park, NC, USAc), Marissa Lassere, M.B.B.S.,
Ph.D., F.R.A.C.P. (Epidemiology, St George Hospital, Ko-
garah, Australia), Stefan Lohmander, M.D., Ph.D. (Ortho-
paedics, University of Lund, Lund, Sweden), Jean-Pierre
Raynauld, M.D. (Rheumatology, University of Montreal
and Arthrovision, Montreal, PQ, Canada), Randall Stevens,
M.D. (Hoffman-LaRoche Inc., Nutley, NJ, USA), Saara Tot-
terman, M.D., Ph.D., (Virtual Scopics, Pittsford, NY USA),
James Witter, M.D. (Food and Drug Administration (FDA),
Washington, DC, USA), and Thasia Woodworth, M.D.
(Pﬁzer, Groton, CT, USAd). The panel met in New Orleans,
LA, on October 29, 2002 prior to the Workshop in Bethesda
to deﬁne a preliminary set of MRI features to include in
whole-organ assessment of the knee and to review the rel-
ative strengths and weaknesses of various imaging proto-
cols for multi-feature, multi-site MRI. The ﬁndings of the
panel were presented to the participants of the Workshop
in Bethesda for open discussion. In addition, data sets
from previous clinical trials and epidemiological studies of
OA were analysed with respect to the metrological proper-
ties of the measurement methods employed. One of these
analyses examined the internal construct validity of
WORMS1, a whole-organ MRI scoring method for assess-
ing structural abnormalities in the knee, using data from
a clinical trial of OA (Study 1). The results of this analysis
were presented to the participants of the Workshop in
Bethesda for discussion. Subsequent to the Workshop,
a second clinical epidemiology data set (Study 2) using
WORMS but with a more extensive range of pathology
was also analysed in order to strengthen the validity of
the ﬁndings from the ﬁrst analysis. This report summarizes
these two analyses.
Although MRI offers the capability for visualising multiple
structural pathologies in OA, quantitative measurement of
abnormalities has largely been focussed on cartilage vol-
ume and thickness (see Eckstein et al., in this supplement).
Since quantifying many of the other abnormalities felt to be
important to OA is not yet easily achievable, it seems rea-
sonable to use semi-quantitative scoring, as in the WORMS
system1. Semi-quantitative scoring, however, introduces an
ordinal level of measurement, which limits use to non-para-
metric statistics and precludes mathematical operations
such as calculating a change score2.
One method for assessing the degree to which an ordinal
measurement scale behaves as a unidimensional interval
scale and therefore may be amenable to thesemathematical
operations is Rasch analysis3,4. An update on the applica-
tion of Rasch and its use in the evaluation of functional status
questionnaires has been presented by Wolfe5, and Rasch
analysis has been used to evaluate other musculoskeletal
outcome measures6,7. This approach is indicated when it
is proposed to summate a set of items to give a total score,
as unidimensionality (the measurement of a single con-
struct) is a requirement for such summation8. Rasch analysis
can help determine if a scale is unidimensional, valid at the
item level (e.g., categories 0e3), and whether or not bias
exists in any items (e.g., by gender) (4e7). These attributes
bDr Eckstein is currently at Paracelsus Private Medical University
Salzburg, Austria & Chondrometrics GmbH, Munich, Germany.
cDr Hsu is currently at Centocor, Philadelphia, PA, USA.
dDr Woodworth is currently at Novartis, Basel, Switzerland.address the internal construct validity of a measuring sys-
tem. They should be ascertained prior to using the data
from a scale in any explanatory mode (e.g., does the size
of an osteophyte relate to a given clinical ﬁnding?). Where
data do meet the expectations of the Rasch model, a trans-
formation to interval scaling occurs, making mathematical
operations, such as the calculation of a change score,
appropriate. Thus, Rasch analysis was used in this study
to evaluate the internal construct validity of WORMS with
respect to summing each subscale across the whole joint
(e.g., summing regional osteophyte scores) and summing
several subscales together to form a total whole-joint score.
Methods
STUDY 1
A database of WORMS evaluations from a clinical trial of
OA knee was kindly made available by the investigators and
management of the Roche NI-15713 study. This study was
a multi-centre, prospective, randomized, placebo-controlled,
ﬁve arm, parallel group, dose-ranging trial of 24 weeks dura-
tion including methods development for assessing OA joints.
A total of 504 subjects recruited from 58 clinical sites in 1998
were randomly assigned to receive one of four doses of test
drug or matching placebo tablets. Ambulatory subjects of
either sex with knee OA who met the following clinical crite-
ria were eligible: age 45e85 years, at least moderate knee
pain on the Western Ontario and McMaster Universities
scale on at least 15 days in the previous month, and either
stiffness <30 min or crepitus on motion of the target knee.
At screening the target knee had to have met all of the fol-
lowing radiographic criteria based on the OARSI Atlas9
and using ﬁxed-ﬂexion radiography with a positioning
frame10: grade 1 or 2 joint-space narrowing of the medial ti-
biofemoral compartment, joint-space width 1.5 mm of both
the medial and lateral tibiofemoral compartments, and grade
1, 2 or 3 osteophytes. The mean age of the subjects was
60.6 years and 72% were women. The mean BMI was
30.0, with 35% of the patients having a BMI less than 28.
Sixty percent of the patients entering the study used nonste-
roidal anti-inﬂammatory drugs (NSAIDs) on a regular basis
for the treatment of OA.
MRI of a target knee was performed at baseline in the
504 patients originally enrolled. A total of 150 of these
patients also received a 24-week follow-up MRI examina-
tion of the same knee before the study was terminated.
Only data from baseline images of these 150 patients
were included in this analysis. MRI was performed with
1.5 T whole body scanners using a circumferential extrem-
ity coil. Imaging included axial T2-weighted fast spin-echo
(FSE) through the patella (repetition time (TR)¼ 3500 ms,
echo time (TE)¼ 60 ms, echo-train length (ETL)¼ 16, ﬁeld
of view (FOV)¼ 12 cm, slice thickness¼ 3 mm with no in-
terslice gap, matrix¼ 256 256 pixels, anterioreposterior
frequency encoding, two excitations); coronal T2-weighted
FSE with spectral fat suppression (TR¼ 3500 ms,
TE¼ 60 ms, ETL¼ 8, FOV¼ 12 cm, slice thick-
ness¼ 3 mm with no interslice gap, matrix¼ 256 256
pixels, superioreinferior frequency encoding, two excita-
tions); sagittal dual-echo FSE (TR¼ 3500 ms, TE¼ 20 ms
and 60 ms, ETL¼ 8, FOV¼ 12 cm, slice thickness¼ 3 mm
with no interslice gap, matrix¼ 256 256 pixels, superior-
einferior frequency encoding, two excitations, wide superior
and inferior external saturation bands to limit vascular pul-
sation artifacts); sagittal multi-echo spin-echo with spectral
fat suppression (TR¼ 2500 ms, TE¼ 15 ms, 30 ms, 45 ms
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interslice gap, matrix¼ 256 160 pixels, 16 kHz band-
width, anterioreposterior frequency encoding, one excita-
tion, wide superior and inferior external saturation bands
to limit vascular pulsation artefacts) for measuring T2 relax-
ation time of the articular cartilage; and sagittal T1-weighted
three-dimensional spoiled gradient echo with spectral fat
suppression (TR¼ 58 ms, TE¼ 6 ms, ﬂip angle¼ 40(,
FOV¼ 12 cm, 60 contiguous 2-mm slices, matrix¼ 256
192 pixels, superioreinferior frequency encoding, one exci-
tation, wide superior and inferior external saturation bands
to limit vascular pulsation artifacts).
Radiographic and MRI protocol design, site training,
imaging quality control and image analysis were performed
by a central radiology service (Synarc, Inc.). Semi-quantita-
tive scoring of the acquired images was performed by radi-
ologists experienced in WORMS using a Sun Workstation
equipped with MRVision software (MRVision Inc., Menlo
Park, CA).
STUDY 2
A database of WORMS evaluations from the Boston Os-
teoarthritis Knee Study (BOKS) was analysed. The BOKS is
a completed natural history study of knee OA. To be eligible
for the study, a person had to have primary clinical knee OA
and meet American College of Rheumatology (ACR) criteria
for this disorder. Of 324 subjects who entered the study,
86% completed a full comprehensive follow-up at a later
time point. The source of recruited subjects has been de-
scribed in detail elsewhere11. Of 324 subjects who entered
the study, 193 men and 19 women received care from the
Veterans Administration Health Care System and were re-
cruited from the outpatient clinics there. Eight men and
104 women were recruited from the community. The aver-
age interval between examinations was approximately 15
months, with visits scheduled at 15 and 30 months. These
comprehensive examinations consisted of an MRI of the
most affected knee, a comprehensive set of radiographs in-
cluding a semi-ﬂexed ﬂuoroscopically positioned PA radio-
graph using the method of Buckland-Wright, a semi-ﬂexed
weight-bearing skyline view also per Buckland-Wright’s
protocol and at the baseline and 30 month visits, and
a weight-bearing lateral radiograph of each knee per the
Framingham Osteoarthritis Study protocol11.
AllMRI studieswereperformedwith aSigna1.5 TMRI sys-
tem (General Electric Corp., Milwaukee,WI) using a phased-
array knee coil. A positioning device was used to ensure
uniformity among patients with the patient reclining in the su-
pine position with a fully extended knee immobilized in the
knee coil and the foot perpendicular to the table. The imaging
protocol included sagittal dual-echo spin-echo images
(TR¼ 2200 ms, TE¼ 20 ms and 80 ms, FOV¼ 11e12 cm,
slice thickness¼ 3 mm with a 1-mm interslice gap,
matrix¼ 256 192 pixels, one excitation); and coronal and
axial dual-echo spin-echo images with the same imaging
parameters but spectral fat suppression. Phase encoding
was anterior to posterior on sagittal and left to right on coronal
sequences. Imaging quality control was performed by amus-
culoskeletal radiologist at the time of acquisition and prior to
reading. All MR images were scored using WORMS by the
same radiologist (AG) who scored images in Study 1.
THE WORMS FOR KNEE OA
Detailed descriptions and deﬁnitions are provided else-
where1. This score entails assessment of 14 features atmultiple intra-articular sites (see summary of features and
scaling in Table I). The cartilage, bone (oedema, attrition
and cysts) and osteophyte abnormalities are assessed in
15 different regions including the medial and lateral patellar
facets, the medial and lateral femoral condyles and tibial
plateaus (each divided into anterior, central and posterior
sections) and the subspinous region of the tibia (the latter
is not included in cartilage assessment). Synovial cavity dis-
tension is scored without distinction between synovial
hypertrophy and effusion. Periarticular cysts and bursae
(popliteal, meniscal, tibioﬁbular, anserine, infra-patellar
and pre-patella) are also recorded. These features are
scored with semi-quantitative scales varying from 0e1 to
0e7. For example, a 0e1 scale indicates normal or abnor-
mal whereas 0e3, 0e6 and 0e7 scales represent increas-
ingly severe abnormalities relative to the area or volume of
the region being scored. These scores can been aggre-
gated by feature or compartment to produce medial tibiofe-
moral, lateral tibiofemoral and patellofemoral compartment
scores as well as total knee scores1.
RASCH ANALYSIS
The Rasch model is a logistic function of the difference
between the level of structure impairment of the individual
(e.g., degree of bone marrow oedema (BME)) and the
item score (e.g., 0e3). The Rasch model places both these
structure abnormalities and item calibrations on a single
metric scale. This is done by using computer software
which determines if the data meet model expectations,
that is, it is expected that the more severe the structural
pathology, the higher the subscale score. Where data
meet model expectations, a transformation of the ordinal
raw score into a linear metric (logit) is achieved. The logit
or log-odds unit is the mathematical unit of Rasch measure-
ment. One logit increases the odds of observing the event
speciﬁed in the measurement model by a factor of 2.718,
the value of ‘‘e’’, the base of ‘‘natural’’ or Napierian loga-
rithms used for the calculation of ‘‘log-’’ odds. All logits are
the same length with respect to this change in the odds of
observing the indicative event and thus this provides the
transformation into the metric scale.
Fit to the model is determined by a range of statistics at
the model level, and at the individual item and person level.
Two of the model statistics are itemeperson interaction
Table I
Subscale scoring in the WORMS
0 1 2 3 4 5 6 7
Cartilage - Morph 
Bone Edema 
Bone Cysts 
Bone Attrition 
Osteophytes 
ACL,PCL* 
MCL,LCL* 
Menisci
Synovitis 
Cysts/Bursae 
Loose Bodies 
Abbreviations: Morph¼morphology; ACL¼ anterior cruciate lig-
ament; PCL¼ posterior cruciate ligament; MCL¼medial collateral
ligament; LCL¼ lateral collateral ligament. *The ACL, PCL, MCL
and LCL are scored as independent items and are grouped here
for convenience; hence, 14 features in total are scored.
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dard deviation of 1. A third is an itemetrait interaction statis-
tic reported as a chi-square, reﬂecting the property of
invariance of the scale across the construct. For individual
person and item ﬁt statistics, residual statistics are pre-
sented, and also a chi-square test examines the invariance
of each item across respondents grouped across the trait
(known as Class Intervals).
In these analyses, an ‘‘item’’ refers to a structural sub-
scale score at a given anatomical site. Where items
have more than two response options (i.e., they are polyt-
omous, e.g., 0e3, as with most of the WORMS subscales)
the scoring system can also be evaluated to see if it is
working as intended. Traditional external construct validity
may compare the magnitude of abnormality between mo-
dalities, e.g., measuring cartilage defects by arthroscopy
and MRI. Rasch analysis examines the internal construct
validity without reference to any external scale. Where
an item is scored such that a higher value reﬂects greater
structural abnormality, it would be expected that this in-
crease in score is reﬂected by an increase in the level
of abnormality of the underlying construct. This construct
is derived from the raw score, summed across recommen-
ded components, and its subsequent transformation by the
logistic function of the Rasch model into the logit measure.
Sometimes, an increase in the item score does not coin-
cide with an increase in the underlying trait. Where this
is the case, items are said to display disordered thresholds
(a threshold is the transition point between any two adja-
cent categories of an item, i.e., the score for an individual
pathological feature at a given intra-articular site). This dis-
ordering can come about because of several reasons, in-
cluding distributional issues (categories that have not been
used), or the inability of the rater to discriminate properly
across categories. Where disordered thresholds occur
it is necessary to collapse categories (e.g., rescore a
7-point scale into a 4-point scale) until such a time that
their values accord with an increase in the underlying
construct.
Within the framework of Rasch measurement, the scale
should also function in the same way, irrespective of which
group is assessed. The scores for speciﬁc sites should
remain the same between groups, such as older and youn-
ger age groups or between men and women, at any given
level of structural abnormality being measured. Conse-
quently, given the same level of abnormality, responses to
items should not vary by group. This type of analysis is
given the name Differential Item Functioning (DIF). The
presence of DIF is a violation of the assumption of unidi-
mensionality and needs to be addressed where present.
In Study 1 below, DIF is examined for age, gender and
body mass index, while in Study 2 DIF is examined for
left/right knee, and for visit (i.e., does the scale remain sta-
ble over different assessments?).
Thus, Rasch analysis is primarily undertaken when sev-
eral items are summed together to give an overall score
for a unidimensional construct, such as summing cumula-
tive scores from multiple WORMS features to create a par-
ticular compartment score or a whole knee score. A single
summary item (encompassing the whole joint rather than
speciﬁc intra-articular sites) such as synovitis can only be
assessed in the context of a higher order construct, that
is, where the item is added together with others from differ-
ent subscales to make some wider construct such as
a whole knee score. The synovitis item was therefore
merged with items from other subscales in order to
test whether or not it was working in a hierarchical fashionin the context of a postulated whole knee score (i.e.,
a higher order construct; perhaps the most important con-
struct for OA which involves all the structures of the
knee). The Rasch analysis was done using RUMM 2020
software12. Bonferroni adjustments were made for multiple
testing13.
Results
STUDY 1
Data from 137 subjects (comprising the placebo group)
with mean age of 61 (range 44e85), 74% women, were
available for this analysis. Eleven of the 14 WORMS sub-
scales had over 85% of subjects at the ﬂoor of the scale
(i.e., scoring 0) indicating the absence of site-speciﬁc
abnormalities in many patients. With this very large ﬂoor
effect, Rasch analysis was restricted (because there were
too few non-zero cases) to examining the cartilage morphol-
ogy and marginal osteophyte subscales, together with the
synovitis single site subscale embedded within the former.
In addition, sites from these three scales were combined
to examine the feasibility of an overall score of structural
impairment.
Initially, the scoring of anatomical sites within each sub-
scale was reviewed to determine whether their response
categories were working as intended, for example, a higher
category reﬂecting greater amount of structural damage. All
sites were found to display disordered thresholds, suggest-
ing that the existing categories were not reﬂecting the
expected increase in magnitude of structural impairment.
Consequently sites were rescored, for example, 0123456
into 0011222. Following this strategy, two sites had to be di-
chotomised (i.e., they had to be rescored as 0 and 1) after
which all sites displayed ordered thresholds.
Cartilage morphology
After collapsing the categories as described above, the
sites scored from this scale showed good ﬁt to the Rasch
model (item ﬁt 0.280; SD 1.032; person ﬁt 0.289; SD
0.759; chi-square interaction signiﬁcance 0.120). The aver-
age person location was 3.026 indicating that the centre
of the measurement scale (location 0) was considerably
offset from that of the patients (meaning that most of the
patients were at the low end of the scale). The person
separation index of 0.693 indicates that the scale was not
able to discriminate between groups of patients, that
is, no subgroups could be resolved in this population.
None of the sites showed DIF by age, gender or body
mass index.
Marginal osteophytes
After collapsing categories all sites from the scale
showed good ﬁt to the Rasch model (item ﬁt 0.269; SD
0.930; person ﬁt 0.204; SD 0.726; chi-square interaction
signiﬁcance 0.198). Once again the patients were consider-
ably offset from the site locations (mean location 4.04).
One of the marginal osteophytes items (superior patella re-
gion) showed DIF. This was DIF by gender group, meaning
that at any given level of structural abnormality, women
were given a higher score on this region.
Overall structural impairment
All the sites from the two subscales above, together with
synovitis, were taken together to examine if a higher order
A120 P. G. Conaghan et al.: Examining a whole organ MRI scoring system for OAconstruct of global structural impairment (a limited structure
whole knee score) was feasible. Of the 29 total items, 22
(11 cartilage morphology; 10 marginal osteophytes and
the synovitis item) formed a Rasch unidimensional scale
(item ﬁt 0.769; SD 0.834; person ﬁt 0.348; SD 0.564;
chi-square interaction signiﬁcance 0.080). With a person
separation of 0.804, the scale was able to discriminate three
separate groups of subjects at different levels of structural
impairment. The synovitis item ﬁtted within this scale, and
did not display any form of DIF.
STUDY 2
Images of 336 OA knees scored by three readers were
included in this analysis. Once again, many of the sub-
scales had a substantial proportion of subjects at the ﬂoor
of the scale (i.e., scoring 0).
Cartilage morphology
None of the items had ordered thresholds, and 11 of the
14 items had to be dichotomised; one item retained three
categories and two items four categories. After collapsing
categories the items showed poor ﬁt to the Rasch model
(item ﬁt 1.006; SD 2.464; person ﬁt 0.523; SD 0.950; chi-
square interaction chi-square 226.5 (df 56); P< 0.0001).
The average person location was 5.341 indicating that
the centre of the measurement scale (location 0.0) was
considerably offset from that of the patients (Fig. 1). None
of the items showed DIF by visit, but two showed DIF by
left/right knee. A unidimensional scale could not be identiﬁed
using all the items in this subscale.
Marginal osteophytes
Of the 16 sites summated in this scale, only two required
dichotomisation. Another four items were rescored with
three categories, the remainder rescored with four through
seven categories. After collapsing categories items showed
poor ﬁt to the Rasch model (item ﬁt 0.794; SD 1.574; per-
son ﬁt 0.199; SD 0.595; chi-square interaction chi-square
263.9 (df 64); P< 0.0001)). Patients were offset from the
item locations (mean location 1.84), but not so much as
with the scales above. There was no DIF by visit, and just
one item showed DIF by left/right knee. Despite this, a unidi-
mensional scale could not be identiﬁed using all the items in
this subscale.Bone attrition
Of the 14 sites summated to make this subscale, six
retained their original scoring structure, some needed col-
lapsing and ﬁve needed dichotomisation. After collapsing
categories, items showed poor ﬁt to the Rasch model, but
the removal of four sites, including both patella sites,
resulted in ﬁt to the model (item ﬁt 1.354; SD 1.188; per-
son ﬁt 0.445; SD 0.510; chi-square interaction chi-square
45.3 (df 30); P¼ 0.04). Again patients were offset from the
item locations (mean location 4.641) with a substantial
number without impairment. There was no DIF by visit,
and just one item showed DIF by left/right knee.
Bone marrow edema
Of the 15 items in this scale, ﬁve worked as originally
intended, ﬁve required some collapsing of categories and
ﬁve needed dichotomisation. After collapsing categories
items showed poor ﬁt to the Rasch model, but the removal
of four sites resulted in ﬁt to the model (item ﬁt 0.731; SD
0.935; person ﬁt 0.472; SD 0.874; chi-square interaction
chi-square 54.6 (df 33); P¼ 0.01). Patients were offset from
the item locations (mean location 3.283) with a substantial
number at the ﬂoor of the scale. There was no DIF by visit,
and just one item showed DIF by left/right knee.
Sub-articular cysts
All 15 of the sites in this scale needed dichotomisation.
After collapsing categories, items showed poor ﬁt to the
Rasch model (item ﬁt 0.321; SD 0.939; person
ﬁt 0.172; SD 0.608; chi-square interaction chi-square
117.8 (df 60); P¼<0.0001). Patients were offset from the
item locations (mean location 1.903). There was no DIF
by visit or left/right knee. The removal of ﬁve of the 15 sites
resulted in ﬁt to the model, but at the expense of reliability
(person separation index), which was too low to form
a scale.
Overall structural impairment
As with Study 1, an attempt was made to take all the sites
from the subscales above, together with synovitis, to deter-
mine whether a higher order construct of global structural
impairment (a limited structure whole knee score) was fea-
sible. This was not possible with the sites scored from thisFig. 1. Person (individual subject) e item (MRI score) distribution map for the WORMS Cartilage Morphology subscale for all anatomical sites
(Study 2).
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mine if surface features (cartilage, BME, cysts, attrition
and osteophytes) could be summed by compartment (patel-
lofemoral, medial and lateral femorotibial); again, it was not
possible to construct a unidimensional scale.
Discussion
This analysis of an ordinal, whole-organ scoring method
demonstrates the difﬁculties associated with constructing
semi-quantitative measurement systems. It should be noted
that these analyses summated individual pathological
features across every evaluated intra-articular site. When
summating the scores in this way, the measurements did
not always work out as intended. This does not indicate that
a particular anatomical feature lacks importance in an OA
scoring system. Rather, it suggests that the current proposed
summation used in these analyses does not always produce
a valid summed score for a unidimensional scale.
Traditional evaluation of outcome scales involves attri-
butes such as reliability, validity and responsiveness.
Recently emphasis has been placed upon internal construct
validity, that is, the requirement of unidimensionality of
a scale. While factor analytic procedures have been widely
used to ascertain this aspect, increasingly Rasch analysis is
seen as more appropriate for ordinal-based measurement
as the assumptions of factor analysis require interval level
data14. Consequently, Rasch is now widely applied to ques-
tionnaire-based ordinal scales (e.g., the Health Assessment
Questionnaire (HAQ) and Oxford hip assessments)6,7.
However, little work has been done to date on imaging mea-
surement systems15, yet the same requirements for unidi-
mensionality apply.
In addition to unidimensionality, ﬁtting data to the Rasch
model also allows for a detailed examination of the scoring
structure for individual features. This is often difﬁcult to con-
ceptualise, as scores are usually developed with increasing
severity in mind. However, such a grading should work con-
sistently with the total value of the construct under investi-
gation, that is, the increasing score for the site should
work consistently with the total score for the construct
(summed across all sites).
It is important to state that certain limitations were inherent
in these analyses. In Study 1 the small sample size limited the
degree of precision of person and item location estimates.
The ﬂoor effects observed were not unexpected, given that
this was a population selected for relatively mild structural
OA. The distribution of responses across the categories
within an item in both studies may also have limited the
precision of the threshold estimates and consequently the
interpretation of disordered thresholds. Nevertheless, the ex-
isting scaling of items (e.g., 0e7) does not seem to work as
intendedwhensummated in thewaysexamined in this paper.
Different MRI sequences between the two studies may have
resulted in some differences in scoring. DIF was very uncom-
mon andwhere present could also have been affected by the
precision of the estimates, or be a chance ﬁnding. However,
the fact that we found similar results in both studies, where
Study 1 represented predominantly ‘early’ disease andStudy
2 provided a greater range of pathology, argues in favour of
the interpretations.
It is likely that a whole-organ disease, such as OA, will
require evaluation with a whole-organ scoring method.
Such MRI methods may eventually support automated as-
sessment using speciﬁcally designed software that providesquantitative interval scale measurement. However simpler,
semi-quantitative scoring needs evaluation to determine its
usefulness for both the clinician and clinical researcher. In-
deed, the metric properties of any measurement technique
require rigorous and critical appraisal. The present ﬁndings
have raised important questions about summating ordinal
scores frommultiple anatomical sites used in these analyses.
Further work is required to identify appropriate aggregation
strategies for site scores that provide valid measurement.
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